Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Waters, Protea Biosciences

Premium

VICAM, a business of Waters, this week introduced its new Myco6in1+ LC/MS/MS immunoaffinity column for detection of mycotoxins.

The column can screen simultaneously for seven major mycotoxin families and isolate at least 14 chemically-distinct mycotoxins, the company said.


Protea Biosciences this week introduced an extended service portfolio from its Mass Spec Imaging Center.

The center offers imaging mass spec services using techniques including LAESI-MSI and MALDI-MSI, allowing two- and three-dimensional mapping of samples including tissues, biofilms, cell cultures, bacteria, and fungal colonies.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.